Publications

All Publications
Fact Sheets
Reports
Graphics

GHTC
Research and Development: A Critical Driver of Universal Health Coverage

Examine how R&D of new drugs, vaccines, diagnostics, and other tools is a critical driver of universal health coverage.

PDF

WHO funding for R&D: By the numbers

Illustrates how and how much the World Health Organization is investing across its R&D programs and how they are financed.

PDF

PATH/Gabe Bienczycki
WHO Roadmap for Access: 2019-2023

Provides analysis of the World Health Organization’s (WHO) draft Road Map for Access to Medicines, Vaccines and Other Health Products including an overview of the contents and the potential implications if approved. This roadmap, which outlines WHO’s proposed workplan on access for the period 2019–2023, will be presented to the WHO Executive Board in January 2018 for input and then will go before the World Health Assembly in May for endorsement.

PDF

Multilateralism for GHTC: Overview brief

Provides an overview of the opportunities and institutions GHTC targets in the multilateral arena, why GHTC advocates in that arena, and how our members and partners can participate in these opportunities.

PDF

Enhancing GHSA’s role in supporting global health R&D to advance health security

Provides background on the Global Health Security Agenda (GHSA) and limitations with its current structure, and offers recommendations to expand the comprehensiveness of the program in advancing global health security through the adoption of a new action package on global health R&D.

PDF

Return On Innovation: Learn how global health R&D delivers for your state

Interactive online tool and individualized state fact sheets documenting how US investments in global health R&D are delivering economic and health benefits across American states.

View

GHTC
Bolstering BARDA’s role in combatting naturally occurring threats and emerging infectious diseases

Provides background on the mission of the Biomedical Advanced Research and Development Authority (BARDA), its engagement to date in combatting naturally occurring threats and emerging infectious diseases, and limitations that hinder its ability to sustain and increase activities in this space.

PDF

GHTC
Pandemic and All-Hazards Preparedness Reauthorization Act priorities

Recommends actions to bolster BARDA’s role in developing medical countermeasures against naturally occurring threats and emerging infectious diseases through the 2018 reauthorization of the Pandemic and All-Hazards Preparedness Act.

PDF

GHTC
US agency series: Global health R&D across the US government

This six-part fact sheet series examines the contributions of US government agencies to advancing global health R&D. The series includes the US Agency for International Development, National Institutes of Health, Centers for Disease Control and Prevention, Biomedical Advanced Research and Development Authority, Department of Defense, and Food and Drug Administration.

View

GHTC
Who we are: Global Health Technologies Coalition

Describes GHTC’s mission and membership. It is the first in a four-part introductory fact sheet series on the importance of global health R&D.

PDF

GHTC
Why does global health R&D matter?

Explains why global health R&D is vital in achieving a safer, healthier world. It is the second in a four-part introductory fact sheet series on the importance of global health R&D.

PDF

GHTC
What has global health R&D achieved?

Outlines the historical progress achieved through global health R&D and the impact of US leadership. It is the third in a four-part introductory fact sheet series on the importance of global health R&D.

PDF

GHTC
Why is global health R&D a smart investment for America?

Describes the health, security, and economic returns from investing in global health R&D. It is the fourth in a four-part introductory fact sheet series on the importance of global health R&D.

PDF

Research and development at the 69th World Health Assembly

Provides background and analysis on the agenda items under discussion at the 69th World Health Assembly which could impact global health R&D.

PDF

A pipeline of promise: Global health research and product development process

Infographic illustrating the R&D process for global health technologies and the challenges faced in advancing products through the R&D pipeline.

PDF

Health innovation and the Sustainable Development Goals

Provides background on the Sustainable Development Goals (SDGs), the critical role of health innovation in achieving the goals, and actions the US government can take to support health R&D to meet the SDGs.

PDF

Turning ambition into action: The critical role of health innovation in achieving the Sustainable Development Goals

Provides an overview of the content and global health R&D indicators recommended in the report Measuring global health R&D for the post-2015 development agenda, which was commissioned by the Council on Health Research for Development, GHTC, the International AIDS Vaccine Initiative, Medicines for Malaria Venture, PATH, and the TB Alliance.

PDF

New products hold the key to health improvement worldwide

Outlines the important contributions that the US government has made to global health R&D and why it is critical that the United States continue to support the global health research pipeline.

PDF

Saving lives through research: USAID's role in creating breakthrough global health products

Explains the critical role of the US Agency for International Development (USAID) in global health R&D.

PDF

The FDA's role in global health: Helping safe, effective health tools reach people in need worldwide

Outlines the US Food and Drug Administration's (FDA) role in global health R&D and offers recommendations for how the FDA can continue to strenghten its engagement.

PDF

How the US government can improve coordination for global health R&D

Outlines the need for greater interagency coordination among US government agencies and programs engaged in global health R&D and provides a set of recommendations for achieving this goal.

PDF

GHTC, DSW, Policy Cures
2015 and beyond: The role of innovation for health in a new development framework

Explores the importance of health R&D to achieving development objectives and offers recommendations from GHTC, DSW, and Policy Cures on how the United Nations can ensure innovation is included in the post-2015 agenda.

PDF

Improving health at home and abroad

Examines how the US Food and Drug Administration (FDA) can maximize its investment and global impact. This brief offers actionable recommendations that the FDA can implement to strengthen the United States’ legacy in global health.

PDF

Bill & Melinda Gates Foundation, DSW, GHTC, Policy Cures
Creating the tools of tomorrow: Investing in global health R&D

Examines advances in global health tools over the last few years, as well as the need for new and innovative partnerships, and increased investment in global health R&D. Created by the Bill & Melinda Gates Foundation, DSW, GHTC, and Policy Cures.

PDF

Exploring the role of the US government in a future advance market commitment

Provides specific recommendations for US policymakers about the role and engagement of the US government in a future advance market commitment.

PDF

The transformative power of global health research

Examines how US leadership in global health research helps to save lives worldwide and provides domestic economic benefits.

PDF

Incentives and innovative financing for global health product development

Explores different incentives and innovative financing mechanisms and their roles in global health product development.

PDF

Our members work to improve health worldwide